Emergent BioSolutions | EBS - EPS Прибыль на акцию

Биржевая цена
8.81
Изменение за день
0.19 2.20%
Ежемесячно
10.13%
Ежегодный
94.05%
Q2 прогноз
8.43




Eps Изменить Дата
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Akebia Therapeutics USD -0.04 0.04 2025-12
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.14 0.06 2025-12
ANI Pharmaceuticals USD 2.33 0.29 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Coherus Biosciences USD -0.43 0.06 2025-12
Emergent BioSolutions USD -0.77 0.29 2023-12
Exelixis USD 0.97 0.19 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Ironwood Pharmaceuticals USD -0.01 0.25 2025-12
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Lonza CHF 6.07 1.92 2025-06
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Myriad Genetics USD 0.04 0.33 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Pacira USD 0.06 0.64 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Sanofi EUR 1.53 1.38 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12
Xoma USD -1.59 2.43 2024-09